Status:
COMPLETED
The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Patients with Irritable Bowel Syndrome (IBS) often link their symptoms to foods. Interest in dietary management recently increased, including the use of a gluten-free diet. To investigate relation of...
Detailed Description
The study is a randomized, double-blind, placebo-controlled, cross-over trial. The aim is to assess the effects of gluten-free diet (GFD) compared to gluten-containing diet (GCD) in IBS patients and ...
Eligibility Criteria
Inclusion
- Adult patients with IBS according to Rome IV criteria
Exclusion
- allergy or documented intolerance to food,
- severe cardiovascular, hepatic, neurological or psychiatric disease
- serious gastrointestinal disease: including celiac disease and inflammatory bowel diseases (IBD),
- diabetes
- bowel dysfunction related to previous surgery
- pregnant or lactating women
- usage of antibiotics within 4 weeks before inclusion
- strict avoidance of foods
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03869359
Start Date
October 1 2018
End Date
October 1 2019
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magnus Simrén
Gothenburg, Västra Götland, Sweden, 40530